[Chinese expert consensus for invasive fungal disease in patients after hematopoietic stem cell transplantation(2023)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):92-97. doi: 10.3760/cma.j.issn.0253-2727.2023.02.002.
Abstract
摘要
相似文献
1
[Chinese expert consensus for invasive fungal disease in patients after hematopoietic stem cell transplantation(2023)].《造血干细胞移植患者侵袭性真菌病中国专家共识（2023年版）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):92-97. doi: 10.3760/cma.j.issn.0253-2727.2023.02.002.
2
An open-label trial of the prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation: study protocol.一项在接受异基因造血干细胞移植患者中进行伏立康唑预防性给药的开放标签试验：研究方案。
Nagoya J Med Sci. 2018 Nov;80(4):591-595. doi: 10.18999/nagjms.80.4.591.
3
Case report: Ganoderma weberianum invasive fungal disease (IFD) during allogeneic hematopoietic stem cell transplantation (HSCT).病例报告：异基因造血干细胞移植（HSCT）期间的韦氏灵芝侵袭性真菌病（IFD）。
Transpl Infect Dis. 2021 Aug;23(4):e13647. doi: 10.1111/tid.13647. Epub 2021 Jun 13.
4
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.异基因造血干细胞移植患者侵袭性真菌感染的管理：都灵经验。
Front Cell Infect Microbiol. 2022 Jan 7;11:805514. doi: 10.3389/fcimb.2021.805514. eCollection 2021.
5
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.血液系统疾病患儿造血干细胞移植后侵袭性真菌病的联合抗真菌治疗
Transpl Infect Dis. 2019 Jun;21(3):e13066. doi: 10.1111/tid.13066. Epub 2019 Mar 27.
6
Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.造血细胞移植后宏基因组下一代测序诊断侵袭性真菌病的临床性能。
Front Cell Infect Microbiol. 2024 Mar 25;14:1210857. doi: 10.3389/fcimb.2024.1210857. eCollection 2024.
7
High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis.即使在抗真菌预防措施下，非T细胞去除的单倍体相合异基因造血干细胞移植后侵袭性真菌感染的发生率仍很高。
Bone Marrow Transplant. 2021 Jul;56(7):1750-1753. doi: 10.1038/s41409-021-01260-7. Epub 2021 Mar 29.
8
A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation.化疗或干细胞移植的血液学患者中预防侵袭性真菌感染的预防方案综述。
Expert Rev Hematol. 2023 Jul-Dec;16(12):963-980. doi: 10.1080/17474086.2023.2290639. Epub 2023 Dec 18.
9
Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.评估一种用于预防异基因造血干细胞移植后侵袭性霉菌感染的一级抗真菌预防方案。
J Oncol Pharm Pract. 2022 Jun;28(4):794-804. doi: 10.1177/10781552211011221. Epub 2021 Apr 28.
10
[Invasive fungal infection management in patients with hematological malignancies].[血液系统恶性肿瘤患者侵袭性真菌感染的管理]
Rinsho Ketsueki. 2022;63(9):1270-1278. doi: 10.11406/rinketsu.63.1270.
引用本文的文献
1
Efficacy and Safety of Amphotericin B Colloidal Dispersion for Patients with Invasive Fungal Disease and Febrile Neutropenia: A Registry-Based, Multicenter, Retrospective, Real-World Study.两性霉素B胶体分散剂用于侵袭性真菌病和发热性中性粒细胞减少症患者的疗效和安全性：一项基于注册登记的多中心回顾性真实世界研究
Infect Drug Resist. 2025 May 13;18:2475-2487. doi: 10.2147/IDR.S494985. eCollection 2025.
2
The effectiveness and safety of posaconazole enteric-coated tablet versus oral suspension in invasive fungal infections.泊沙康唑肠溶片与口服混悬液治疗侵袭性真菌感染的有效性和安全性。
Sci Rep. 2024 Nov 13;14(1):27887. doi: 10.1038/s41598-024-79512-x.
3
Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.造血细胞移植后宏基因组下一代测序诊断侵袭性真菌病的临床性能。
Front Cell Infect Microbiol. 2024 Mar 25;14:1210857. doi: 10.3389/fcimb.2024.1210857. eCollection 2024.
4
Real-World, Multicenter Case Series of Patients Treated with Isavuconazole for Invasive Fungal Disease in China.中国使用艾沙康唑治疗侵袭性真菌病的真实世界多中心病例系列
Microorganisms. 2023 Sep 4;11(9):2229. doi: 10.3390/microorganisms11092229.
本文引用的文献
1
Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study.受者和供者 PTX3 rs2305619 多态性增加了亲缘单倍体干细胞移植后侵袭性真菌感染的易感性：一项前瞻性研究。
BMC Infect Dis. 2022 Mar 26;22(1):292. doi: 10.1186/s12879-022-07298-2.
2
American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.美国移植与细胞治疗学会系列，第2部分：造血细胞移植受者曲霉病的管理与预防
Transplant Cell Ther. 2021 Mar;27(3):201-211. doi: 10.1016/j.jtct.2020.10.003.
3
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新：来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
4
A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016.基于全州注册和行政数据库数据链接的血液肿瘤患者侵袭性真菌病的人群分析：2005-2016 年。
BMC Infect Dis. 2019 Mar 21;19(1):274. doi: 10.1186/s12879-019-3901-y.
5
Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.接受强化化疗后使用抗霉菌活性三唑类药物进行一级预防的急性髓系白血病患者中出现的突破性侵袭性真菌病：意大利关于定义和管理的共识协议
Med Mycol. 2019 Apr 1;57(Supplement_2):S127-S137. doi: 10.1093/mmy/myy091.
6
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.欧洲成人血液学患者原发性抗真菌预防指南：白血病患者感染欧洲会议更新推荐摘要。
J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.
7
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.血液病患者侵袭性霉菌感染的突破：当前概念和未来方向。
Clin Infect Dis. 2018 Oct 30;67(10):1621-1630. doi: 10.1093/cid/ciy473.
8
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗：2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
9
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.ECIL-6白血病和造血干细胞移植患者侵袭性念珠菌病、曲霉病和毛霉病治疗指南。
Haematologica. 2017 Mar;102(3):433-444. doi: 10.3324/haematol.2016.152900. Epub 2016 Dec 23.
10
Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.中国异基因造血干细胞移植患者的抗真菌预防：一项多中心前瞻性观察研究。
J Hematol Oncol. 2016 Sep 23;9(1):97. doi: 10.1186/s13045-016-0305-y.
Zotero 插件